Thromboxane Production in Human Lung During Cardiopulmonary Bypass: Beneficial Effect of Aspirin?

This publication has 13 references indexed in Scilit:

• Cardiac-derived thromboxane A2
  The Journal of Thoracic and Cardiovascular Surgery, 1993
• Thromboxane A2 mediates increased pulmonary microvascular permeability following limb ischemia.
  Circulation Research, 1989
• Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats
  American Heart Journal, 1989
• Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism.
  Circulation Research, 1988
• Endothelial-secreted arachidonic acid metabolites modulate polymorphonuclear leukocyte chemotaxis and diapedesis in vitro
  Blood, 1988
• Synthesis and structure of the platelet aggregation factor thromboxane A2
  Nature, 1985
• Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.
  Circulation, 1980
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
  Nature, 1976
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
  Proceedings of the National Academy of Sciences, 1975
• Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
  Nature New Biology, 1971